Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,237,290 papers from all fields of science
Search
Sign In
Create Free Account
bleomycin/cyclophosphamide/doxorubicin/prednisone/vincristine protocol
Known as:
CA-BOP
, CHOP-B
, BLEO/CTX/DOX/PRED/VCR
Expand
A chemotherapy combination consisting of bleomycin, cyclophosphamide, doxorubicin, prednisone, and vincristine.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Broader (4)
Antineoplastic Combined Chemotherapy Protocols
Bleomycin
Cyclophosphamide
cisplatin/cyclophosphamide/etoposide protocol
Doxorubicin
Doxorubicin Hydrochloride
Prednisone
Vincristine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Cytotoxic Components of Pereskia bleo (Kunth) DC. (Cactaceae) Leaves
S. Malek
,
Sim Kae Shin
,
N. Wahab
,
Hashim Yaacob
Molecules
2009
Corpus ID: 2779491
Dihydroactinidiolide (1) and a mixture of sterols [campesterol (2), stigmasterol (3) and β-sitosterol (4)], together with the…
Expand
Highly Cited
2006
Highly Cited
2006
Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.
Qi Liu
,
L. Fayad
,
+12 authors
P. Mclaughlin
Journal of Clinical Oncology
2006
Corpus ID: 11503359
PURPOSE Advanced-stage follicular lymphoma is considered incurable. The pace of improvements in treatment has been slow. This…
Expand
Highly Cited
2003
Highly Cited
2003
Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B.
B. Peterson
,
G. Petroni
,
+9 authors
A. Gottlieb
Journal of Clinical Oncology
2003
Corpus ID: 28340067
PURPOSE The array of options for the initial management of follicular small cleaved lymphoma (FSCL) and follicular mixed lymphoma…
Expand
Review
2003
Review
2003
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
J. Seymour
,
B. Pro
,
+11 authors
P. Mclaughlin
Journal of Clinical Oncology
2003
Corpus ID: 26109684
PURPOSE Standard therapy for patients with stage I-II indolent lymphoma has been involved-field radiation therapy (IF-XRT), which…
Expand
Highly Cited
1994
Highly Cited
1994
Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma.
A. Avilés
,
S. Delgado
,
M. Nambo
,
S. Alatriste
,
J. Díaz-Maqueo
International Journal of Radiation Oncology…
1994
Corpus ID: 24305224
Highly Cited
1993
Highly Cited
1993
Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas.
R. Pryzant
,
M. Meistrich
,
G. Wilson
,
Barry Brown
,
P. Mclaughlin
Journal of Clinical Oncology
1993
Corpus ID: 19255831
PURPOSE Treatment of lymphomas with combination chemotherapy with or without radiation therapy (XRT) can result in long-term or…
Expand
Highly Cited
1990
Highly Cited
1990
Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma.
M. Maor
,
W. Velasquez
,
L. Fuller
,
K. Silvermintz
Journal of Clinical Oncology
1990
Corpus ID: 31984100
Thirty-four patients with stages IE and IIE gastric lymphoma were treated with chemotherapy and radiotherapy combinations without…
Expand
Highly Cited
1984
Highly Cited
1984
Stages IE and IIE non‐Hodgkin's lymphomas of the stomach: Comparison of treatment modalities
M. Maor
,
Brian Maddux
,
+7 authors
Roland W. Bennett
Cancer
1984
Corpus ID: 25636975
Seventy‐nine patients with Stages IE and IIE non‐Hodgkin's lymphomas of the stomach were treated between 1953 and 1980. The…
Expand
Highly Cited
1977
Highly Cited
1977
Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy.
R. Fisher
,
V. Devita
,
B. Johnson
,
R. Simon
,
R. Young
American Journal of Medicine
1977
Corpus ID: 40798895
Highly Cited
1977
Highly Cited
1977
Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).
A. Skarin
,
D. Rosenthal
,
W. Moloney
,
E. Frei
Blood
1977
Corpus ID: 11115655
Seventy-three patients with advanced non-Hodgkin lymphoma were treated with bleomycin, Adriamycin, cyclophosphamide, vincristine…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE